Phillips Kuhl is a member of the Scientific Advisory Board of Glycosyn. Mr. Kuhl is the co-founder of Cambridge Healthtech Institute (CHI) and has been president of the company since the company began in 1992. Mr. Kuhl has been responsible for the steady and profitable growth of the business to its current scope of organizing more than 150 conferences and tracks during the current fiscal year, all focused on biotechnology and pharmaceutical issues.

During 2006 CHI acquired Bio-IT World, a leader in electronic publishing covering the implications of informatics and IT for better decision-making for biological and pharmaceutical research. During 2008 CHI acquired Barnett International, a leading provider of training and consulting particular for clinical trial professionals.

Prior to CHI, Phillips spent three years developing the Life Science Division of conferences for IBC US. His prior experience also includes senior positions in consulting, market research and an operating position in a life science company, covering eleven years. Mr. Kuhl received his BA in Economics and in Russian Studies from Haverford College and his MBA from Harvard Business School.